Ambien - Zolpidem
- A - Z: Arthritis Drugs
- A - Z: Drug Costs
- Fatigue / Chronic Fatigue
- Fibromyalgia Medications
- Sleep Medications
- Sleeping Problems
FDA Cuts Recommended Dose of Ambien
The FDA has cut the recommended dose of Ambien. Data has shown that the drug stays in the body longer than previously thought, especially in women or in those who take exteneded release formulations.
Ambien CR: Extended-Release Formulation Of Ambien Has Been Approved
Ambien CR (zolpidem tartrate extended-release tablets), a new extended-release formulation of the prescription sleep aid, Ambien (zolpidem tartrate), has been FDA approved for the treatment of insomnia. Ambien CR is non-narcotic and a non-benzodiazepine, formulated to offer a new indication for sleep maintenance, in addition to sleep induction. Ambien CR, a bi-layered tablet.
Ambien: Is Popular Sleep Medication Causing More Traffic Accidents?
Media outlets reported that Ambien was causing an increasing number of bizarre traffic accidents nationwide. What provoked the news reports which implicated Ambien was a small, six-patient study. Some patients are taking the drug inappropriately and taking to the roads while driving under the influence. Safe use of Ambien requires that patients follow the drugmaker's advice.
Drug Profile: Zolpidem Tartrate (Ambien)
Drug profile and essential information for the drug zolpidem tartrate (Ambien), from UMM.
Patient Information: Ambien / Ambien CR
Patient information for Ambien, from Sanofi-Aventis. Ambien is indicated for the short-term treatment of insomnia. Ambien CR is indicated for the treatment of insomnia.